Meet JYMed at Interphex Week Tokyo 2025

We’re excited to announce that JYMed will be exhibiting at Interphex Week Tokyo from July 9 to 11, 2025, at Tokyo Big Sight (Ariake). This major event brings together over 90 exhibitors and approximately 34,000 professionals from across the pharmaceutical and cosmetics industries. As one of Asia’s top platforms for industry innovation and global business, Interphex Tokyo is a key opportunity for international collaboration.

2 (1) (1) (1) (1) (1) (1)

About JYMed

JYMed is a science-driven pharmaceutical company specializing in the development, manufacturing, and commercialization of peptide-based products. We offer end-to-end CDMO services for pharmaceutical, cosmetic, and veterinary partners worldwide.

Our product portfolio includes a wide range of peptide APIs, including Semaglutide and Tirzepatide, both of which have successfully completed U.S. FDA DMF filings.

Our manufacturing arm, Hubei JXBio, operates cutting-edge peptide API production lines that meet cGMP standards from both the U.S. FDA and China’s NMPA. The site features 10 large- and pilot-scale lines and is supported by a robust QMS and comprehensive EHS framework.

JXBio has passed GMP audits by the U.S. FDA and China’s NMPA and is recognized by leading pharmaceutical companies for its commitment to safety, quality, and environmental responsibility. 

MAIN PRODUCTS

3

Let’s Connect

To learn more about our capabilities or to schedule a meeting during the show:

•Global API & Cosmetic Inquiries: +86-150-1352-9272

•API Registration & CDMO Services (U.S. & EU): +86-158-1868-2250

•Email: jymed@jymedtech.com

•Address: Floors 8 & 9, Building 1, Shenzhen Biomedical Innovation Industrial Park, 14 Jinhui Road, Kengzi Subdistrict, Pingshan District, Shenzhen, China.